For more than 130 years, our research-driven pharmaceutical company has created innovative medicines for people and animals. Boehringer Ingelheim is one of the pharmaceutical industry’s top 20 companies and to this day remains family-owned.
Every day, our 50,000 employees create value through innovation in our three business areas: human pharmaceuticals, animal health and biopharmaceutical contract manufacturing. In 2016, Boehringer Ingelheim achieved net sales of around 15.9 billion euros. At more than three billion euros, R&D expenditure corresponds to 19.6 per cent of net sales.
Social responsibility comes naturally to Boehringer Ingelheim. It’s why we are involved in social projects such as the “Making More Health” initiative. Boehringer Ingelheim also actively promotes workforce diversity and benefits from our employees’ different experiences and skills. Environmental protection and sustainability is the focus of everything we do.
More information about Boehringer Ingelheim can be found on www.boehringer-ingelheim.com or in our annual report: http://annualreport.boehringer-ingelheim.com.